Patent details

Basic Information

Publication number:

EP3150218

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161956081

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES

French Title of Invention:

INTERFÉRON CIBLÉ MANIFESTANT DES ACTIVITÉS APOPTOTIQUES ET ANTI-TUMORALES PUISSANTES

German Title of Invention:

GEZIELTES INTERFERON MIT POTENTEN APOPTOTISCHEN UND ANTITUMORWIRKUNGEN

SPC Number:

Dates

Filing date:

19/09/2008

Grant date:

08/09/2021

EP Publication Date:

05/04/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/09/2021

EP B1 Publication Date:

08/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/09/2021

Expiration date:

19/09/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/09/2021

 

 

Name:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Address:

1111 Franklin Street, 12th Floor, Oakland CA 94607-5200, United States (US)

Inventor

1

Name:

Xuan, Caiyun

Address:

United States (US)

2

Name:

Morrison, Sherie L.

Address:

United States (US)

3

Name:

Huang, Tzu-Hsuan

Address:

United States (US)

Priority

Priority Number:

994717 P

Priority Date:

21/09/2007

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; C07K 14/55; A61K 47/68; A61P 35/02; A61P 35/04;

Publication

European Patent Bulletin

Issue number:

202136

Publication date:

08/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages